Crohn's Disease Clinical Trials in Philadelphia

Showing 41-52 of 52 trials

Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics

NCT02316678

The investigators will test the hypothesis that that greater efficacy of anti-tumor necrosis factor (antiTNF) therapy results in reduced need for bowel resection surgery, fewer serious infections, and reduced short term mortality risks, and therefore has a more favorable benefit to harm profile than corticosteroids for inflammatory bowel disease.

Colitis, UlcerativeInflammatory Bowel DiseasesCrohn's Disease

University of Pennsylvania9,573 participantsStarted Sep 2014

Philadelphia, Pennsylvania, United States

COMPLETEDPHASE117 miles

Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects

NCT01258205

The purpose of this study is to assess the safety and tolerability of AMG 139 following multiple intravenous (IV) or subcutaneous (SC) dose administration in healthy subjects and in subjects with mild to severe Crohn's disease (CD).

Crohn's Disease

AstraZeneca48 participantsStarted Feb 2011

Berlin, New Jersey, United States • Stony Brook, New York, United States • Oklahoma City, Oklahoma, United States +4 more locations

COMPLETEDPHASE349 miles

Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

NCT00105300

The goal of this study is to test whether adalimumab can induce clinical remission in subjects with active Crohn's disease who have been initially treated with infliximab and either lost response or discontinued its use as a result of intolerance to the drug.

Crohn's Disease

Abbott300 participantsStarted Oct 2004

Huntsville, Alabama, United States • Roseville, California, United States • San Diego, California, United States +53 more locations

Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics

Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects

Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

Crohn's Disease Trials in Other Cities

A Multi-Center Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Moderate-to-Severe Crohn's Disease

Fecal Calprotectin Collection Protocol

A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease

A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy

Remission in Subjects With Crohn's Disease, Open Label Extension

Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease

Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease

Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease

The Impact of Vitamin D on Disease Activity in Crohn's Disease

Other Conditions in Philadelphia